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Characterization of heterogeneous proteins as large as 150,000 u was performed by a 
quadrupole mass spectrometer by using electrospray ionization (ESI). We were able to 
determine not only the molecular weight, but the detailed heterogeneity for the large 
glycoproteins as well. The successful application was facilitated by the optimization of the 
instrument in the high mass-to-charge range up to m/z 4000, where the multiply charged 
envelopes of the 150,000-u glycoproteins were found. For the analysis of clinically important 
monoclonal antibodies mass spectral data acquired by this method were consistent with the 
carbohydrate analysis and were useful in resolving the monosaccharide data into glycoform 
variations. In the case of the characterization of other large, heterogeneous proteins such as 
elongation factor 3 and bovine serum albumin, the quadrupole ES1 mass spectrometer 
provided adequate mass resolution and high mass measurement accuracy to discern the 
modification and degradation of the proteins. 
(J Am Sot Mass Spectrom 1996, 7, 1219-1226) 
0 2996 American Society for Mass Spectromety 
T he revolution in molecular biology has been of enormous benefit to pharmaceutical research. Bioengineering is used routinely to produce pro- 
teins not only for direct therapeutic use, but also for 
facilitating the discovery of small molecules. The rapid 
development of biotechnology has, therefore, resulted 
in increasing demands for fast and accurate assays to 
characterize the proteins that are produced. Several 
questions crucial to protein research include the fol- 
lowing: (1) Does the protein have the same amino acid 
sequence as indicated by the gene sequence? (2) Has 
the protein been modified post-translationally? (3) How 
pure is the protein after expression and purification? 
(4) Does the protein undergo degradation under dif- 
ferent cellular or laboratory conditions? (5) How repro- 
ducible is the expression process from various cell 
lines or batches? Many of these questions can now be 
addressed rapidly and accurately by mass spectrome- 
try- 
Although mass spectrometry has traditionally been 
applied to the study of low molecular weight com- 
pounds, it recently joined the revolution in the bio- 
logical sciences. This transition is mainly due to the 
development of electrospray ionization (ESI) and ma- 
trix-assisted laser desorption (MALD) mass spectrome- 
try that enables intact protein molecules to be ionized 
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and accurately measured by a mass spectrometer [l, 
21. The sensitivity of these mass spectrometric tech- 
niques is in the low picomole range, similar to that of 
conventional bioassays such as sodium dodecylsul- 
fate-polyacrylamide gel electrophoresis and amino 
acid analysis. However, mass spectrometry provides 
inherently superior accuracy and resolution when 
compared to these bioassays. As such, mass spectrom- 
etry, in conjunction with other bioanalytical method- 
ologies, is rapidly becoming a standard technique for 
the analysis of biological samples. 
After its invention 131, ES1 found little use in mass 
spectrometry until Fenn and co-workers [2, 4, 61 
demonstrated that this novel means could deliver mul- 
tiply charged proteins into the gas phase for mass 
analysis. For many denatured proteins, the average 
charge state is approximately one positive charge per 
1000 u. Today, molecules with molecular weight (MW) 
< 60,000 can be analyzed easily by electrospray ioniza- 
tion-mass spectrometry (ESI/MS) 111. For large, het- 
erogeneous proteins, particularly glycoproteins, even 
the most current mass spectrometric instrumentation is 
still challenged because of the high demands in mass- 
to-charge range, mass resolution, and sensitivity. 
Mass spectrometry analysis of intact monoclonal 
antibodies (MAbs) with MW of 150 ku illustrates some 
of the difficulties. For example, a mass-to-charge range 
up to m/z 4000 is necessary to reveal the full pattern 
of ions generated by ES1 because the protein is large 
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and carbohydrates carry fewer charges. Moreover, high 
mass resolution is required for resolving glycoproteins 
( - 150,000 u) differing by one monosaccharide residue. 
These requirements pose extreme difficulty for a 
quadrupole mass spectrometer. ES1 was employed in 
earlier studies to characterize intact MAbs by quadru- 
pole [9-111, time-of-flight [12], and magnetic sector 
mass spectrometry [lo]. Because of the lack of ade- 
quate high mass capability and/or mass resolution in 
these studies, ESI/MS was limited in the direct analy- 
sis of these large glycoproteins 19-121. Although the 
molecular weights of the intact MAbs were measured 
by ESI/MS, it was not possible to determine the de- 
tailed microheterogeneities of the proteins. Therefore, 
microheterogeneities were only characterized when the 
protein was reduced to MAb fragments [ll, 13, 141. 
The present study demonstrates for the first time that 
ES1 on a quadrupole instrument can provide informa- 
tion regarding not only the molecular weight for large 
glycoproteins (150,000 u), but microheterogeneities as 
well. The applications of this method are illustrated in 
examples encountered in the research and develop- 
ment of large glycoproteins of pharmaceutical interest. 
The analysis of other large, heterogeneous proteins and 
mass measurement accuracy are also discussed. 
Experimental 
Materials and Methods 
Bovine serum albumin (BSA), myoglobin, and L-methi- 
onyl-arginyl-phenylalanyl-alanine acetate . H z0 
(MRFA) were obtained from Sigma Chemical Co. (St. 
Louis, MO) and were used without further purifica- 
tion. Human antitrypsin antibody was purchased from 
Calbiochem (San Diego, CA). Elongation factor 3 (EF-3) 
was obtained from Dr. K. Chakraburtty, University of 
Wisconsin at Green Bay. Proteins of MCP, ERK, and 
Raf were provided by Bayer Research Center (BRC, 
West Haven, CT). The peptide for tuning the instru- 
ment in the high mass range was synthesized in the 
core facility of BRC with a MW of 3259.6. The sequence 
of the peptide is AC QVIRNALASP GSGGDLGEAI 
REQPEQARLA L. The purification of MAbA and 
MAbB1,2,3 was performed in the following order: 
cation exchange chromatography on S-Sepharose 
(Pharmacia, Uppsala, Sweden), anion exchange chro- 
matography on Q-Sepharose, and size exclusion chro- 
matography on Sephacryl S-200HR. Solvents used were 
all high-performance liquid chromatography grade (J. 
T. Baker, Phillipsburg, NJ) and were used without 
further purification. All chromatography supports used 
in the purification of MAbs were purchased from Phar- 
macia LKB (Piscataway, NJ). Nitrogen gas was ob- 
tained from the boil-off of a 160-L pressure-building 
liquid nitrogen Dewar (Minnesota Valley Engineering, 
New Prague, MN) that provided dry, pure nitrogen at 
200 lb/in.*. 
A myoglobin and MRFA mixture was used for 
tuning and routine calibration of the instrument. The 
mixture was made in the following manner: stock 
solutions of myoglobin and MRFA were prepared by 
dissolving 0.9 mg of horse skeletal muscle myoglobin 
in 1 mL of a solution of 50:50 methanol:water contain- 
ing 5% acetic acid, and 0.6 mg of MRFA was dissolved 
in 1 mL of a solution of 50:50 methanol:water contain- 
ing 5% acetic acid. The calibration and tuning stan- 
dard was made from the two stock solutions: 50 PL of 
myoglobin and 12 PL of MRFA were diluted with 538 
PL of a 50:50 methanol:water solution in a polypropy- 
lene vial. Aliquots were stored at - 80 “C and removed 
prior to use to minimize freeze/thaw effects. The tun- 
ing mixture was infused into the mass spectrometer at 
a rate of 3 pL/min on a Harvard Apparatus (model 
22, South Natick, MA) syringe pump. 
Monosaccharide composition analysis was per- 
formed on the desalted monoclonal antibodies by us- 
ing the methanolysis procedure. Briefly, the samples 
were methanolyzed with 1-M methanolic-HCI at 80 “C 
for 24 h. The sugar methyl glycosides were N- 
acetylated in the presence of pyridine and acetic anhy- 
dride at room temperature followed by trimethylsilyla- 
tion by using TRISIL reagent (Pierce, Rockford, IL). 
The separation and quantitation of various monosac- 
charides were achieved on a capillary gas chromate 
graph equipped with FID by using a 30-m DB-1 col- 
umn (J & W Scientific, Folsom, CA). 
Apparatus 
High-performance liquid chromatography was carried 
out by using a Michrom Bioresources (Auburn, CA) 
ultrafast microprotein analyzer (UMA) equipped with 
a lo-port automated sample injector and a variable 
wavelength UV/vis detector set at 280 run with a 
0.3-PL (2-mm) flow cell. The microbore column was 
preceded by a microguard column (Michrom Biore- 
sources). The eluents were A: 2% acetonitrile in water 
with 2% acetic acid and B: 98% acetonitrile in water 
with 2% acetic acid. Gradient elution from 0 to 100% B 
over 14 min at a flow of 100 pL/n$n on a PLRP-S 
(Michrom Bioresources) 8-pm 1000-A 1.0~mm x 50- 
mm microbore column provided separation of the pro- 
teins from their accompanying salts in less than 15 
min. 
Electrospray ionization was performed on a Finni- 
gan TSQ 7000 triple quadrupole mass spectrometer 
(Finnigan MAT; San Jose, CA) fitted with a Finnigan 
ES1 interface. Protein samples were introduced without 
any splitting into the electrospray interface through an 
untreated fused-silica capillary with a 50-pm i.d. and 
190-pm o.d. coupled to the high-performance liquid 
chromatograph (HPLC) with a stainless steel zero 
dead-volume union (Upchurch Scientific, Oak Harbor, 
WA). A positive voltage of 4500-5000 V was main- 
tained on the electrospray needle throughout all the 
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experiments. The ES1 capillary was heated to 200 “C. 
Nitrogen was introduced as a sheath gas at a pressure 
of 50 lb/in.’ and auxiliary nitrogen gas at 30 mL/min 
was also introduced to improve sensitivity and repro- 
ducibility. 
Quadrupole 1 was operated in the high mass-to- 
charge range and was scanned from m/z 1800 to 4000 
over 5 s for the MAbs, EF-3, and BSA. The electron 
multiplier was set at 1200-1400 V. This setting re- 
sulted in a typical total ion count (TIC) of 1 X 10’ 
counts. All protein spectra were acquired in profile 
mode. Profile data were averaged by using a peak 
width of m/z 100 mu for the large proteins. A mass 
defect of m/z 0 mu at m/z 0 and m/z 300 mu at m/z 
1000 was used for data processing. Mass deconvolu- 
tion of multiply charged ions was performed by using 
Finnigan biochemistry software. 
Results and Discussion 
Mass Spectromet y Tuning and Mass Spectrum for 
Antitypsin Antibody 
Our preliminary data and previous studies [9-111 indi- 
cated that the ion envelopes for MAbs were observed 
in the high mass-to-charge range (m/z 2000-4000) 
during electrospray ionization. Therefore, we used a 
synthetic peptide that gives a singly charged ion at 
m/z 3260.6 to tune and determine the mass resolution 
at the high mass-to-charge range. Peak profiles (see 
Figure 1) were examined to determine the proper pa- 
rameters for mass resolution. Figure lc (showing a 
peak width at half height of m/z - 6) illustrates a 
typical tuning result in the high mass-to-charge range, 
where lower resolution is tuned to maintain sensitiv- 
ity. Figure lb shows the resulting peak profile when 
the mass spectrometer was tuned at a slightly higher 
resolution (approximately m/z 3-u peak width at half 
the height of the peak). Figure la illustrates the highest 
resolution achieved in which unit mass resolution was 
demonstrated in this high mass-to-charge range; the 
isotope peaks at the m/z 3260.6 were clearly resolved. 
The sensitivity of the instrument at these three resolu- 
tion settings was measured by the number of ion 
counts detected as marked in the upper right comer of 
the Figures la-c. The peak heights were 552,340, 
186,679, and 11,757 counts for low (Figure lc), medium 
(Figure lb), and high resolution (Figure la), respec- 
tively. It is apparent that the sensitivity decreased only 
threefold from low to medium resolution, but dropped 
dramatically, that is, almost SO-fold, when the instru- 
ment was tuned at unit mass resolution at the high 
mass-to-charge range. 
One type of glycosylation heterogeneity of an MAb 
may arise from the incomplete substitution or sequen- 
tial deletion of monosaccharide residues in the sugar 
chain, which would result in several protein compo- 
nents differing by the residue masses, for example, 
galactose (162 u), fucose (146 u), or sialic acid (291 u). 
Figure 1. Peak profiles of a peptide with a molecular weight of 
3259.6 when tuned in high (top), medium (middle), and low 
(bottom) mass resolution. 
To detect this type of microheterogeneity of MAbs, it is 
necessary to achieve a mass resolution that resolves 
components differing by - 150 u (the average residue 
mass of a monosaccharide) in the mass range of 150,000 
u (the average MW of MAbs) after the deconvolution 
of the multiply charged envelopes. Since we observed 
in preliminary experiments that the MAbs carried - 50 
charges, the actual instrumental mass resolution re- 
quired was m/z - 3 u (150 u/50 charges). The objec- 
tive was to tune the mass spectrometer for adequate 
mass resolution to detect different glycosylated forms 
of the proteins without significant loss of sensitivity; 
thus, medium resolution (m/z 3 u) in the mass-to- 
charge range of - 3000 was chosen for this study. 
The ES1 mass spectrum of the antitrypsin antibody, 
a MAb, was acquired by using the aforementioned 
conditions; the spectrum is shown in Figure 2. Antit- 
rypsin antibody is a commercially available glycopro- 
tein and has been characterized biologically 1151 as 
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Figure 2. A mass-to-charge ratio spectrum (a) and deconve 
luted mass spectrum (b) of the antitrypsin antibody. 
well as by mass spectrometry 191. The upper panel of 
Figure 2 shows the multiply charged ion envelope for 
the antibody, which was then subjected to a deconvo- 
lution algorithm to generate the final spectrum. As 
predicted, a resolution of m/z 3-u resolved multiple 
peaks in each multiply charged state because of the 
heterogeneity of the glycoprotein. After the deconvolu- 
tion of the acquired data, the peaks corresponding to 
individual hexose sugar deletions (- 162 u) were 
clearly identified as shown in the lower panel of Figure 
2. The masses of the constituents (148,195; 148,357; and 
148,516 u) were in agreement with the early measure- 
ment of the average mass of 148,484 u for the same 
source of the protein 191; however, the heterogeneity of 
the protein had not been resolved in the previous 
study [9]. Our results suggest that it is possible for a 
quadrupole mass spectrometer to measure the 150-ku 
glycoproteins and resolve the individual glycosylation 
heterogeneity. 
Characterization of Other Monoclonal Antibodies 
Four other MAbs of clinical significance-MAbA, 
MAbBl, MAbB2, and MAbB3-were also analyzed in 
our study, and the results are discussed in subsequent 
text. The spectrum of MAbA is given in Figure 3. The 
upper panel illustrates the multiply charged ions; the 
peaks that were due to microheterogeneities for every 
a 
b 
Figure 3. Mass-to-charge ratio spectrum (a) and deconvoluted 
mass spectrum (b) of the MAbA antibody. 
charge state were well resolved. The deconvoluted 
spectrum is shown in the lower panel of Figure 3; here, 
it is evident that at least seven constituents were de- 
tected in this sample because of the heterogeneity. The 
mass difference of - 162 u among the constituents 
suggests that the heterogeneity is due to hexose dele- 
tion. Carbohydrate analysis has shown that the MAb 
has cy-galactose residues that are partially substituted 
on the terminal p-galactose residues (data not shown 
here). Therefore, the seven constituents that mass spec- 
trometry detected are likely due to the sequential dele- 
tion of the galactose residues on the complex N-linked 
chains. 
From the deconvoluted electrospray spectra of 
MAbBl, MAbB2, and MAbB3 in Figure 4, the follow- 
ing points were observed: (1) the measured MW of the 
MAbBl was considerably higher (at least 1500 u higher) 
than those of MAbB2 and MAbB3; (2) although the 
measured MWs of the MAbB2 and MAbB3 were simi- 
lar (- 148,486 uJ, the extent of glycosylation hetero- 
geneity of the proteins from the MAbB3 was much 
higher than that of the MAbB2; (3) the observed het- 
erogeneity is similar for the MAbBl and MAbB2 even 
though the measured MWs of the two proteins were 
different. 
Data from total carbohydrate composition analysis 
for the antibodies were used to interpret the observa- 
tions (Figure 5). Overall, the MAbBl antibody con- 
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Figure 4. Deconvoluted mass spectra of (a) MAbBl, (b) MAbBZ, 
and (cl MAbB3. 
sisted of higher glycosylation levels, that is, 150 
mol/mg IgG, when compared to the MAbB2 (115 
nmol/mg IgG) and MAbB3 (112 nmol/mg IgG). 
Higher levels of total carbohydrates in MAbBl suggest 
that the higher (- 1500 u) MW detected by mass 
spectrometry for the MAbBl is attributable to the car- 
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Figure 5. Monosaccharide compositions of MAbBl, MAbB2, 
and MAbB3. 
bohydrate composition. Typically, all IgG molecules 
incorporate two N-linked oligosaccharide chains each 
on the Asn-297 of the CH, heavy chain domain. In 
addition, glycosylation of the variable regions of heavy 
or light chains in the Fab arm has also been reported. 
Both mass spectrometry detection and carbohydrate 
analysis data in the present study indicate that MAbBl 
may consist of more than two glycan chains, that is, 
glycosylation in the Fab region. This additional 
oligosaccharide chain results in the macroheterogene- 
ity among MAbBl, MAbB2, and MAbB3. 
The multiple mass peaks detected by mass spec- 
trometry for each of the antibodies of MAbBl, MAbB2, 
and MAbB3 were due to the occurrence of extremely 
extensive microheterogeneity. The microheterogeneity 
detected by mass spectrometry revealed that the multi- 
ple constituents differed either by - 162 or - 146 u 
for all the antibodies. Carbohydrate analysis showed 
that galactose (Gal; 162 u) or fucose (Fuc; 146 u) 
residues were substituted on the terminal N-linked 
chains; thus, the microheterogeneity of these MAbs 
was thought to be caused by the sequential deletion of 
Gal or Fuc from the terminus. 
More specifically, mass spectrometry data showed 
that MAbBl had more deletions of Fuc than those of 
MAbB2 and MAbB3. This finding correlated well with 
the monosaccharide composition results: MAbBl had a 
mannose to fucose molar ratio of 3.0:0.7 based on the 
three mannose residues per N-glycan chain as com- 
pared with a molar ratio of 3.0:0.95 for MAbB2 and 
MAbB3. Therefore, both mass spectrometry and 
monosaccharide composition data suggested that fuco- 
sylation of the N-linked oligosaccharides was incom- 
plete for the MAbBl. With regard to the degree of 
galactosylation, a maximum of two galactose (Gal) 
residues could be present on the antibodies for every 
three mannose (Man) residues per glycan chain (com- 
plex, biantennary type), that is, a homogeneous glyco- 
protein without Gal deletion would give a ratio of 
3.0:2.0. However, the mannose to galactose molar ra- 
tios determined by carbohydrate analysis were 3.0:1.5, 
3.0:1.0, and 3.O:l.l for MAbBl, MAbB2, and MAbB3, 
respectively. This carbohydrate structural variation can 
now be interpreted by using the mass spectrometry 
data. The lower than expected ratio is due to the 
deletion of galactose residues as detected by mass 
spectrometry. Also, more galactose deletions in MAbB2 
and MAbB3 than in MAbBl as indicated in Figure 4 
may account for even lower Man:Gal ratios for MAbB2 
and MAbB3. Thus, mass spectrometry data were very 
useful in resolving the monosaccharide analysis data 
into glycoform variations, arising from the galactosyla- 
tion of N-linked glycans. 
It was interesting to note in our study by using 2% 
acetic acid in the ES1 solvent (Finnigan ES1 quadrupole 
mass spectrometer) that the charge-state distributions 
for all the MAbs were in the mass-to-charge range of 
2000-3500 u/e, a much higher range than those ob- 
served for other proteins (BOO-2000 u/e). This high 
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mass-to-charge ratio distribution was also observed in 
other studies for MAbs at different conditions such as 
1% formic acid (Fisons/VG ES1 quadrupole mass spec- 
trometer) [lo, 111 and 4% acetic acid (homemade 
ESI/TOF-MS) [12]. The large size of the MAbs may not 
be the sole cause for such a high mass distribution. 
Typical 3-5% glycosylation of the MAbs may account, 
in part, for the shift of the envelope to high mass-to- 
charge range. 
Although the optimization of the mass spectrometer 
in high mass-to-charge range is crucial to the character- 
ization of MAbs, we observed that it is also important 
to introduce large proteins into the electrospray 
through a I-IPLC. This process eliminated the forma- 
tion of Na and K adduct ions, and thus improved the 
“apparent resolution.” In fact, we found that the mul- 
tiply charged ion envelope for large proteins was seri- 
ously congested due to adduct ion formation even 
when the samples were carefully dialyzed against wa- 
ter prior to infusion into the mass spectrometer. 
Analysis of Elongation Factor 3 and Bovine 
Serum Albumin 
Although mass spectrometry characterization of MAbs 
represents a challenging case to current mass spec- 
trometry instrumentation, it is also important to have 
high mass-to-charge range and relatively high resolu- 
tion of mass spectrometry for the characterization of 
other large or heterogeneous proteins. Figure 6 illus- 
trates the mass spectrum for a large protein-elonga- 
tion factor 3 (EF-3)-with a MW of 116 ku. EF-3 is an 
important protein involved in protein transcription and 
biosynthesis in yeast. While proteins with MW < 60 
ku are becoming more routine, proteins like EF-3 with 
MW > 100 ku still present difficulties for ESI/MS. In 
our preliminary experiment we encountered difficulty 
in the analysis because of the congestion in the multi- 
ply charged ion envelope of the mass spectrum, partic- 
ularly in high charge states, for example, > 100 
charges. When relatively high mass resolution was 
tuned and the sample was introduced through a I-IPLC 
column, the spectrum in Figure 6 was achieved, with a 
multiply charged ion envelope that was well resolved. 
This protein generated over 100 multiply charged peaks 
with charge states from 40 to 155, not commonly 
observed for other proteins. 
Bovine serum albumin (BSA) is a standard protein 
in biological research, and it has been characterized by 
several mass spectrometry laboratories [16-181. The 
measured molecular weights of BSA range from 65,000 
to 67,000 u in ES1 experiments performed in both 
quadrupole and Fourier transformation-ion cyclotron 
resonance instruments. In recent studies, Feng et al. 
[191 reported the measured BSA MW of 66431.5 u, 
which is consistent with the MW of 66,430.3 u sug- 
gested by an independent sequence study [181. BSA 
from the same source (Sigma) was subject to ESI/MS 
analysis in our study, and the spectrum is given in 
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Figure 6. Mass-to-charge ratio spectrum (a) and deconvoluted 
mass spectrum (b) of the EF-3. 
Figure 7. The spectrum shows that the protein was 
heterogeneous and that the major component had a 
MW of 66,430.l u, which agreed with the predicted 
MW of 66,430.3 by gene sequence 1181. The origin of 
the multiple peaks still awaits further characterization. 
It is now clear that the inconsistency that resulted from 
many previous mass spectrometry measurements oc- 
curred not because of the poor accuracy of ESI/MS, 
but because of the inherent heterogeneity of the BSA. 
The reported [16-181 MWs of BSA were actually the 
average MWs of the multiple components as there was 
limited mass resolution in the analyses. 
If the heterogeneity can, in fact, be resolved, there 
would be a significant improvement in the mass mea- 
surement accuracy by ES1 for large proteins. It is gen- 
erally believed that the best mass measurement accu- 
racy of proteins is 0.01% by ESI/MS [l]. This indicates 
that the absolute error would be greater for large 
proteins, for example, f6 for 60,000-u and f 10 for 
100,000-u proteins [13]. However, this assumption 
overlooks the fact that multiple measurements are 
performed by ESI/MS because of the multiply charged 
ion phenomena, that is, every charge state is used once 
to calculate the molecular weight of the protein. Since 
both the standard deviation and standard error are 
inversely proportional to the number of measurements 
(n) [20], the precision and accuracy for protein mass 
measurement are not simply limited by the quadrupole 
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Figure 7. Mass-to-charge ratio spectrum (a) and deconvoluted 
mass spectrum (b) of the BSA. 
precision and accuracy of a single peak. Furthermore, 
many large proteins generate more multiply charged 
peaks, that is, more measurements; therefore, this 
larger n results in a smaller standard deviation and 
standard error. For example, almost 50 multiply 
charged peaks for BSA (66 ku; Figure 7) and 100 for 
EF-3 (116 ku; Figure 6) were generated for the MW 
measurement as compared to typically - 10 peaks for 
a lo-ku protein. Table 1 lists error analysis for various 
proteins with known theoretical gene sequences in our 
study. The relative errors were much smaller than 
0.01%. The mass measurement accuracy for large pro- 
teins such as MAbs cannot be assessed at this time 
Table 1. Results of measured MWs by ESI/MS for 
various proteins 
Theoretical Measured Error Relative 
Protein MW (Da) MW (Da) (Da) error (%) 
MIP2 7845.35 7845.6 
hMCP-1 8665.02 8665.0 
RAF 8946.45 8946.5 
mMCP-1 9860.59 9860.0 
IL-4 15088.43 15089.0 
Stromelysin 19605.92 19605.0 
GST 26984.60 26984.6 
ERK 41144.58 41145.0 
BSA 66430.30 66430.1 
-0.25 0.0032 
+0.02 0.0002 
-0.05 0.0006 
+0.59 0.0060 
+0.57 0.0038 
+0.92 0.0047 
$0.00 - 
-0.42 0.0010 
-0.20 0.0003 
because of the difficulty in obtaining exact MW for 
these proteins. 
Conclusions 
Magnetic sector instruments and Fourier transform- 
mass spectrometry may potentially provide superior 
high mass resolution and mass-to-charge range for the 
analysis of complicated protein samples. However, an 
ES1 quadrupole mass spectrometer is still the most 
widely used configuration in industrial research be- 
cause of its simplicity and adaptability to ESI. Our 
study showed that a quadrupole mass spectrometer 
with electrospray ionization can obtain adequate mass 
resolution and mass-to-charge range to detect both the 
molecular weight and the microheterogeneity for 
150,000-u glycoproteins. In our study, relatively high 
mass resolution allows differentiation of multiple com- 
ponents of heterogeneous proteins, thus improving 
MW measurement accuracy for proteins. We also ob- 
served that charge-state distribution of MAbs during 
electrospray ionization is in the m/z 2000-3500 range 
as compared to m/z 800-2000 for most proteins, which 
is consistent with earlier studies [lo-121. It should be 
emphasized that mass spectrometry data are comple- 
mented by information from other techniques such as 
carbohydrate analysis, Edman sequencing, and amino 
acid analysis in order to understand and solve biologi- 
cal problems. 
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